Earlier this year, neratinib (Nerlynx, Puma Biotechnology) was approved for extended adjuvant treatment of patients with early-stage human epidermal growth factor receptor–positive (HER2+) breast ...

Half of oncologists (49%) surveyed by Medscape see the coming launch of neratinib (Nerlynx, Puma Biotechnology) as an important or very important development in treating HER2-positive breast cancer, ...

Puma Biotechnology announced results from its Phase 3 ExteNET trial of neratinib (PB272) for the extended adjuvant treatment of breast cancer. The ExteNET trial is a double-blind, placebo-controlled ...

Review the side-effects of Neratinib as documented in medical literature. The term "side effects" refers to unintended effects that can occur as a result of taking the medication. In majority of the ...

MONTREAL, Sept. 03, 2020 (GLOBE NEWSWIRE) -- Knight Therapeutics Inc. (TSX:GUD) ("Knight"), a pan-American (ex-US) specialty pharmaceutical company, announced filing of the Supplement to a New Drug ...

While neratinib plus paclitaxel was not superior to trastuzumab plus paclitaxel as first-line treatment for ERBB2-positive metastatic breast cancer in terms of progression-free survival, the ...

Puma Biotechnology, Inc. (PBYI), a development stage biopharmaceutical company, announced an amendment to its licensing agreement with Pfizer for Puma's investigational drug PB272 (neratinib). Puma is ...

• Neratinib comes as a tablet which has to be taken by mouth along with food. • Take the neratinib tablets around the same time every day. • The tablets should not be crushed, opened or split but ...

The FDA has approved neratinib (Puma Biotechnology), a kinase inhibitor, in combination with capecitabine, for the treatment of adult patients with advanced or metastatic human epidermal growth factor ...

Puma Biotechnology, Inc. PBYI is a Los Angeles, CA-based biopharmaceutical company, focused on the development and commercialization of innovative treatments that enhance cancer care. Puma’s stock has ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...